From June 27, 2023 to June 30, 2023, the company has repurchased 119,382 shares, representing 0.09% for $0.15 million. With this, the company has completed the repurchase of 119,382 shares, representing 0.09% for $0.15 million under the buyback announced on June 27, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.61 USD | +4.55% | -4.17% | +82.95% |
15/05 | Atossa Therapeutics Doses Last Patient in Phase 2 Karisma-Endoxifen Trial | MT |
13/05 | Atossa Therapeutics Files $100 Million Mixed-Shelf Offering | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+82.95% | 194M | |
+29.77% | 49.18B | |
+1.00% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.68% | 26.09B | |
-22.99% | 18.71B | |
+8.22% | 13.26B | |
+32.41% | 12.32B | |
-1.62% | 11.99B |
- Stock Market
- Equities
- ATOS Stock
- News Atossa Therapeutics, Inc.
- Tranche Update on Atossa Therapeutics, Inc.'s Equity Buyback Plan announced on June 27, 2023.